Kevin Patrick Danahy, Chief Executive Officer at Pulse Biosciences, Inc. (PLSE), bought 6,500 shares at $2.30 ($15K) on 2022-09-30, disclosed to the SEC on 2022-10-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PLSE | SELL | 2026-02-11 | $1.4M | — | Filing → |
| PLSE | SELL | 2025-10-07 | $85K | — | Filing → |
| PLSE | SELL | 2025-09-22 | $747K | — | Filing → |